Brief: Fate Therapeutics Reports Second Quarter 2022 Financial Results
03/08/2022 22:26
Aug 3 (Reuters) - Fate Therapeutics Inc FATE.O :
* FATE THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND HIGHLIGHTS OPERATIONAL PROGRESS
* REVENUE WAS $18.5 MILLION FOR Q2 OF 2022
* QTRLY NET LOSS PER COMMON SHARE, BASIC AND DILUTED $0.79
* Q2 EARNINGS PER SHARE VIEW $-0.83, REVENUE VIEW $12.9
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3crGZW
Further company coverage: FATE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fate Therapeutics
See all newsBrief: Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial Of FT819 For The Treatment Of Lupus Nephritis
Fate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fate Therapeutics Q2 loss narrows as expenses fall, revenue rises
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview